Latest Insider Transactions at Rockwell Medical, Inc. (RMTI)
This section provides a real-time view of insider transactions for Rockwell Medical, Inc. (RMTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ROCKWELL MEDICAL, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ROCKWELL MEDICAL, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2024
|
Mark H Ravich Director |
SELL
Open market or private sale
|
Indirect |
19,991
-100.0%
|
$39,982
$2.32 P/Share
|
|
Nov 15
2024
|
Mark H Ravich Director |
SELL
Open market or private sale
|
Direct |
10,000
-7.61%
|
$20,000
$2.4 P/Share
|
|
Oct 01
2024
|
Mark Strobeck President and CEO |
SELL
Open market or private sale
|
Direct |
2,163
-1.45%
|
$6,489
$3.69 P/Share
|
|
Oct 01
2024
|
Timothy Chole SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,001
-1.78%
|
$3,003
$3.69 P/Share
|
|
May 21
2024
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,111
+27.86%
|
-
|
|
May 21
2024
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,111
+28.17%
|
-
|
|
May 21
2024
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,111
+27.45%
|
-
|
|
May 21
2024
|
Joan Lau Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,111
+36.39%
|
-
|
|
May 21
2024
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,111
+24.91%
|
-
|
|
May 21
2024
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,111
+28.06%
|
-
|
|
Mar 17
2024
|
Megan C. Timmins EVP, CLO and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,137
-4.0%
|
$3,137
$1.4 P/Share
|
|
Mar 17
2024
|
Mark Strobeck President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,101
-3.92%
|
$6,101
$1.4 P/Share
|
|
Mar 14
2024
|
Jesse Neri SVP, FINANCE |
BUY
Grant, award, or other acquisition
|
Direct |
33,330
+50.0%
|
-
|
|
Mar 14
2024
|
Megan C. Timmins EVP, CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+38.91%
|
-
|
|
Mar 14
2024
|
Mark Strobeck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+39.14%
|
-
|
|
Oct 16
2023
|
Joan Lau Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
May 23
2023
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,715
+17.28%
|
-
|
|
May 23
2023
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,715
+15.53%
|
-
|
|
May 23
2023
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,715
+7.53%
|
-
|
|
May 23
2023
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,715
+16.6%
|
-
|
|
May 23
2023
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,715
+13.71%
|
-
|
|
Mar 17
2023
|
Megan C. Timmins EVP, CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
28,515
+50.0%
|
-
|
|
Mar 17
2023
|
Mark Strobeck President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
55,465
+50.0%
|
-
|
|
Mar 17
2023
|
Marc L Hoffman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,665
+50.0%
|
-
|
|
Mar 17
2023
|
Paul E Mc Garry SVP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
28,515
+50.0%
|
-
|
|
Jun 07
2022
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+20.08%
|
-
|
|
Jun 07
2022
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+21.08%
|
-
|
|
Jun 07
2022
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+16.04%
|
-
|
|
Jun 07
2022
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+8.23%
|
-
|
|
Jun 07
2022
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.56%
|
-
|
|
Jun 17
2021
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+40.16%
|
-
|
|
Jun 17
2021
|
John Peter Mclaughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.74%
|
-
|
|
Jun 17
2021
|
Robert S Radie Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+37.12%
|
-
|
|
Jun 17
2021
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+42.16%
|
-
|
|
Jun 17
2021
|
John G Cooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+32.08%
|
-
|
|
Jun 17
2021
|
Mark H Ravich Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+16.47%
|
-
|
|
Dec 21
2020
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,450
-2.88%
|
$42,450
$1.03 P/Share
|
|
Dec 16
2020
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
521,876
-34.05%
|
$521,876
$1.02 P/Share
|
|
Dec 15
2020
|
David S. Richmond > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
278,124
-4.34%
|
$278,124
$1.11 P/Share
|
|
Dec 11
2020
|
Allen Nissenson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,488
+5.73%
|
-
|
|
Dec 11
2020
|
Andrea Heslin Smiley Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,601
+50.0%
|
$18,601
$1.12 P/Share
|
|
Dec 07
2020
|
Mark H Ravich Director |
BUY
Other acquisition or disposition
|
Indirect |
219,905
+50.0%
|
$219,905
$1.22 P/Share
|
|
Dec 07
2020
|
Mark H Ravich Director |
SELL
Other acquisition or disposition
|
Indirect |
219,905
-100.0%
|
$219,905
$1.22 P/Share
|
|
Jun 30
2020
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
19,813
+13.28%
|
$19,813
$1.93 P/Share
|
|
Jun 30
2020
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,868
+1.31%
|
$4,868
$1.95 P/Share
|
|
Aug 02
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
97
+0.18%
|
$194
$2.42 P/Share
|
|
Jul 31
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,807
+3.31%
|
$3,614
$2.66 P/Share
|
|
Jul 29
2019
|
Richmond Brothers, Inc. |
SELL
Open market or private sale
|
Direct |
179
-0.11%
|
$537
$3.12 P/Share
|
|
Jul 25
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
319
+0.08%
|
$957
$3.06 P/Share
|
|
Jul 24
2019
|
David S. Richmond > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,579
+4.82%
|
$7,737
$3.13 P/Share
|